TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers (PR Newswire)
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the study of its TBS-2025 VISTA inhibiting antibody for the treatment of molecularly defined subsets of AML and other blood related cancers.
Pheronym Awarded $378,000 NSF Phase IIB Supplemental Funding To Accelerate Commercialization and Scale Manufacturing (EIN Presswire)
UF Innovate | Accelerate alum Pheronym, an ag-biotech pest control company, announced it has been awarded $378,000 in National Science Foundation (NSF) SBIR Phase IIB supplemental funding.
FNN™ Selects D-Link to Support Wildfire Intelligence and Emergency Response (EIN Presswire)
UF Innovate | Accelerate resident client FNN is partnering with D-Link to deliver real-time wildfire, lightning and utility intelligence using advanced 5G/4G IoT connectivity solutions.
CasNx publishes research on DNA-guided CRISPR system (Nature Biotechnology)
UF Innovate | Accelerate client company CasNx published research in Nature Biotechnology describing the first DNA-guided CRISPR-Cas12 system, a potential advance for scalable gene-editing therapies and transplant medicine.
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced that the European Commission has granted Orphan Drug designation to SGT-003 for treating Duchenne muscular dystrophy.
UF’s HiPerGator Drives FNN’s AI Wildfire Detection in Verizon Prize Recognition (HPC Wire)
UF Innovate | Accelerate resident client FNN won Verizon’s Disaster Resilience Prize for using AI to enhance disaster response and grid resilience.
UF Innovate | Accelerate Earns Four Honors at InBIA ICBI Conference Awards Ceremony (Global Innovation Institute)
The UF Innovate | Accelerate program was recognized at the InBIA International Business Innovation Association ICBI Conference Awards Ceremony, earning four major honors.
Is Space Biotech Building Its Apps Before Its Operating System? (Hyper Frame)
UF Innovate | Accelerate resident client Aloft Biotechnologies is developing a novel microgravity bioreactor using air-film technology to enable scalable cell culture, highlighting the critical role of hardware innovation in the future of orbital biotechnology.
Synvitta Diagnostics Announces Bold Mission To Advance Multiplex Diagnostic Testing (Alachua Chronicle)
UF Innovate | Accelerate resident client Synvitta Diagnostics, Inc., a biotechnology company developing next-generation diagnostic solutions, announced a strategic partnership between Mitch Glaeser, Co-Founder and Chief Executive Officer, and Rainara Almeida, M.Sc., Co-Founder and Chief Scientific Officer.
Pheronym Awarded $378,000 NSF Phase IIB Supplemental Funding To Accelerate Commercialization and Scale Manufacturing (EIN Presswire)
UF Innovate | Accelerate alum Pheronym, an ag-biotech pest control company, announced it has been awarded $378,000 in National Science Foundation (NSF) SBIR Phase IIB supplemental funding.